Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance?: Cohort study

David P French; Lorna McWilliams; Anthony Howell; D Gareth Evans

doi:10.1016/j.breast.2022.05.001

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study

David P French, Lorna McWilliams, Anthony Howell, D Gareth Evans

Research output: Contribution to journal › Article › peer-review

Abstract

Risk-stratified breast cancer screening may improve the balance of screening benefits to harms.

We assess a potential new harm: reduced screening attendance in women receiving below average-risk (false reassurance) or higher-risk results (screening avoidance). Following initial screening, 26,668 women in the PROCAS study received breast cancer risk estimates, with attendance recorded for two subsequent screening rounds. First-screen attendance was slightly reduced in below-average (85.6%) but not higher-risk women, compared to other women (86.4%). Second-screen attendance increased for women at higher-risk (89.2%) but not below-average, compared to other women (78.8%). Concerns about this potential harm of risk-stratified screening therefore appear unfounded.

Original language	English
Pages (from-to)	47-49
Number of pages	3
Journal	The Breast
Volume	64
Early online date	9 May 2022
DOIs	https://doi.org/10.1016/j.breast.2022.05.001
Publication status	Published - 1 Aug 2022

Keywords

attendance
breast cancer
risk adaptation
risk communication
risk stratification
screening
screening harms

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.breast.2022.05.001Licence: CC BY

Cite this

@article{52a64022f61d4b96a5d21c647a516a4e,

title = "Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance?: Cohort study",

abstract = "Risk-stratified breast cancer screening may improve the balance of screening benefits to harms. We assess a potential new harm: reduced screening attendance in women receiving below average-risk (false reassurance) or higher-risk results (screening avoidance). Following initial screening, 26,668 women in the PROCAS study received breast cancer risk estimates, with attendance recorded for two subsequent screening rounds. First-screen attendance was slightly reduced in below-average (85.6%) but not higher-risk women, compared to other women (86.4%). Second-screen attendance increased for women at higher-risk (89.2%) but not below-average, compared to other women (78.8%). Concerns about this potential harm of risk-stratified screening therefore appear unfounded.",

keywords = "attendance, breast cancer, risk adaptation, risk communication, risk stratification, screening, screening harms",

author = "French, {David P} and Lorna McWilliams and Anthony Howell and Evans, {D Gareth}",

note = "Funding Information: This article presents independent research funded by the National Institute for Health Research ( NIHR ) Programme Grants for Applied Research programme , reference numbers RP-PG-0707-10,031 : “Improvement in risk prediction, early detection and prevention of breast cancer” and Ref: RP-PG-1214-20,016 : “Providing breast cancer risk information as part of national breast cancer screening programme : building an evidence base on benefits and harms to inform a decision to implement ( PROCAS2 ).” All authors are supported by the NIHR Biomedical Research Centre in Manchester ( IS-BRC-1215-20,007 ). The views expressed are those of the author(s) and not necessarily those of the NIHR , or the Department of Health and Social Care . Funding Information: This article presents independent research funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme, reference numbers RP-PG-0707-10,031: “Improvement in risk prediction, early detection and prevention of breast cancer” and Ref: RP-PG-1214-20,016: “Providing breast cancer risk information as part of national breast cancer screening programme: building an evidence base on benefits and harms to inform a decision to implement (PROCAS2).” All authors are supported by the NIHR Biomedical Research Centre in Manchester (IS-BRC-1215-20,007). The views expressed are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care.We are grateful to the women who participated in the present research, and to the assistance of the PROCAS administration team, particularly Jake Southworth. Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2022",

month = aug,

day = "1",

doi = "10.1016/j.breast.2022.05.001",

language = "English",

volume = "64",

pages = "47--49",

journal = "The Breast",

issn = "0960-9776",

publisher = "Churchill Livingstone",

}

TY - JOUR

T1 - Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance?

T2 - Cohort study

AU - French, David P

AU - McWilliams, Lorna

AU - Howell, Anthony

AU - Evans, D Gareth

N1 - Funding Information: This article presents independent research funded by the National Institute for Health Research ( NIHR ) Programme Grants for Applied Research programme , reference numbers RP-PG-0707-10,031 : “Improvement in risk prediction, early detection and prevention of breast cancer” and Ref: RP-PG-1214-20,016 : “Providing breast cancer risk information as part of national breast cancer screening programme : building an evidence base on benefits and harms to inform a decision to implement ( PROCAS2 ).” All authors are supported by the NIHR Biomedical Research Centre in Manchester ( IS-BRC-1215-20,007 ). The views expressed are those of the author(s) and not necessarily those of the NIHR , or the Department of Health and Social Care . Funding Information: This article presents independent research funded by the National Institute for Health Research (NIHR) Programme Grants for Applied Research programme, reference numbers RP-PG-0707-10,031: “Improvement in risk prediction, early detection and prevention of breast cancer” and Ref: RP-PG-1214-20,016: “Providing breast cancer risk information as part of national breast cancer screening programme: building an evidence base on benefits and harms to inform a decision to implement (PROCAS2).” All authors are supported by the NIHR Biomedical Research Centre in Manchester (IS-BRC-1215-20,007). The views expressed are those of the author(s) and not necessarily those of the NIHR, or the Department of Health and Social Care.We are grateful to the women who participated in the present research, and to the assistance of the PROCAS administration team, particularly Jake Southworth. Publisher Copyright: © 2022 The Authors

PY - 2022/8/1

Y1 - 2022/8/1

N2 - Risk-stratified breast cancer screening may improve the balance of screening benefits to harms. We assess a potential new harm: reduced screening attendance in women receiving below average-risk (false reassurance) or higher-risk results (screening avoidance). Following initial screening, 26,668 women in the PROCAS study received breast cancer risk estimates, with attendance recorded for two subsequent screening rounds. First-screen attendance was slightly reduced in below-average (85.6%) but not higher-risk women, compared to other women (86.4%). Second-screen attendance increased for women at higher-risk (89.2%) but not below-average, compared to other women (78.8%). Concerns about this potential harm of risk-stratified screening therefore appear unfounded.

AB - Risk-stratified breast cancer screening may improve the balance of screening benefits to harms. We assess a potential new harm: reduced screening attendance in women receiving below average-risk (false reassurance) or higher-risk results (screening avoidance). Following initial screening, 26,668 women in the PROCAS study received breast cancer risk estimates, with attendance recorded for two subsequent screening rounds. First-screen attendance was slightly reduced in below-average (85.6%) but not higher-risk women, compared to other women (86.4%). Second-screen attendance increased for women at higher-risk (89.2%) but not below-average, compared to other women (78.8%). Concerns about this potential harm of risk-stratified screening therefore appear unfounded.

KW - attendance

KW - breast cancer

KW - risk adaptation

KW - risk communication

KW - risk stratification

KW - screening

KW - screening harms

UR - http://www.scopus.com/inward/record.url?scp=85129912827&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2022.05.001

DO - 10.1016/j.breast.2022.05.001

M3 - Article

C2 - 35569186

SN - 0960-9776

VL - 64

SP - 47

EP - 49

JO - The Breast

JF - The Breast

ER -

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

(MCHP) : Manchester Centre for Health Psychology

Cite this

Does receiving high or low breast cancer risk estimates produce a reduction in subsequent breast cancer screening attendance? Cohort study

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

(MCHP) : Manchester Centre for Health Psychology

Cite this